scholarly article | Q13442814 |
P50 | author | Xiaojuan Li | Q57416456 |
Stephen R Cole | Q89748373 | ||
M Alan Brookhart | Q95597164 | ||
P2093 | author name string | Daniel Westreich | |
P2860 | cites work | Primary medication non-adherence: analysis of 195,930 electronic prescriptions | Q24619145 |
Factors associated with first-fill adherence rates for diabetic medications: a cohort study | Q24646987 | ||
Predictors of first-fill adherence for patients with hypertension | Q24648910 | ||
Completeness of prescription information in US commercial claims databases | Q33575568 | ||
A basic study design for expedited safety signal evaluation based on electronic healthcare data | Q33648230 | ||
Importance of including early nonadherence in estimations of medication adherence | Q33852705 | ||
A structural approach to selection bias | Q33980644 | ||
Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results | Q34001872 | ||
Generalizing evidence from randomized clinical trials to target populations: The ACTG 320 trial | Q34041659 | ||
Evidence of sample use among new users of statins: implications for pharmacoepidemiology | Q34077639 | ||
Design issues for drug epidemiology | Q34078588 | ||
Comparison of pharmacy-based measures of medication adherence | Q34301255 | ||
Primary non-compliance with prescribed medication in primary care | Q35189637 | ||
Characteristics of patients with primary non-adherence to medications for hypertension, diabetes, and lipid disorders | Q35649045 | ||
Counterpoint: the treatment decision design | Q36251759 | ||
Counterpoint: epidemiology to guide decision-making: moving away from practice-free research | Q36251763 | ||
Beyond the intention-to-treat in comparative effectiveness research | Q37063507 | ||
New prescription medication gaps: a comprehensive measure of adherence to new prescriptions | Q37368835 | ||
The incident user design in comparative effectiveness research. | Q38048231 | ||
Generalizing Study Results: A Potential Outcomes Perspective. | Q39202270 | ||
The epidemiology of prescriptions abandoned at the pharmacy | Q39206149 | ||
Correcting for noncompliance and dependent censoring in an AIDS Clinical Trial with inverse probability of censoring weighted (IPCW) log-rank tests. | Q52074171 | ||
Effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease: immortal time bias in observational studies. | Q52949846 | ||
Evaluating Medication Effects Outside of Clinical Trials: New-User Designs | Q52956338 | ||
Confounding by indication | Q71502678 | ||
Evidence of the depletion of susceptibles effect in non-experimental pharmacoepidemiologic research | Q72169848 | ||
The incidence and determinants of primary nonadherence with prescribed medication in primary care: a cohort study | Q87572443 | ||
P433 | issue | 4 | |
P304 | page(s) | 361-364 | |
P577 | publication date | 2018-02-19 | |
P1433 | published in | Pharmacoepidemiology and Drug Safety | Q15759496 |
P1476 | title | Primary non-adherence and the new-user design | |
P478 | volume | 27 |
Q60047628 | Estimating Adherence Based on Prescription or Dispensation Information: Impact on Thresholds and Outcomes. A Real-World Study With Atrial Fibrillation Patients Treated With Oral Anticoagulants in Spain | cites work | P2860 |
Search more.